Skip to main content
SIGA
NASDAQ Life Sciences

Shareholders to Vote on Significant Equity Plan Expansion, Potential 9.86% Dilution

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$4.59
Mkt Cap
$328.848M
52W Low
$4.29
52W High
$9.62
Market data snapshot near publication time

summarizeSummary

SIGA Technologies has filed its definitive proxy statement, revealing a proposal to increase its stock incentive plan by 6.5 million shares, which could lead to a significant 9.86% dilution of outstanding stock.


check_boxKey Events

  • Annual Shareholder Meeting Scheduled

    The company will hold its Annual Meeting of Stockholders on June 9, 2026, to vote on several key proposals.

  • Proposed Equity Incentive Plan Expansion

    Shareholders will vote on an amendment to increase the number of shares available for issuance under the 2010 Stock Incentive Plan by 6,500,000 shares, raising the total authorized to 15,000,000 shares.

  • Significant Potential Dilution

    If approved, the additional 6,500,000 shares represent a potential dilution of approximately 9.86% of the 71,724,097 shares of common stock currently outstanding.

  • Executive Compensation Details

    The filing includes an advisory vote on executive compensation, reporting the CEO's pay ratio at 25:1 for 2025, and details on base salaries, bonuses, and equity awards for named executive officers.


auto_awesomeAnalysis

This definitive proxy statement outlines key proposals for the upcoming annual shareholder meeting, with the most material being the request to significantly increase the share pool for the company's 2010 Stock Incentive Plan. The proposed addition of 6.5 million shares represents a substantial potential dilution of approximately 9.86% of the currently outstanding common stock. While the company justifies this as necessary for attracting and retaining talent and aligning interests, such a large increase in potential equity awards could weigh on shareholder value. Investors should carefully consider the long-term implications of this dilution.

At the time of this filing, SIGA was trading at $4.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $328.8M. The 52-week trading range was $4.29 to $9.62. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SIGA - Latest Insights

SIGA
Apr 28, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7
SIGA
Mar 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
SIGA
Mar 26, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
SIGA
Mar 11, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
7
SIGA
Mar 10, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7